GAGabriel Barros Aulicino

Gabriel Barros Aulicino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gabriel Barros Aulicino has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patent Foramen Ovale Shunting Induced by Tricuspid Regurgitation

    by Heleutério da Conceição Nicolau Madogolele, Manuela Cristina Ribeiro Dias Barroso, Danielle Louvet Guazzelli, Fabiana G. Marcondes-Braga, Gabriel Aulicino, Mônica Avila, Sandrigo Magini, Fábio António Gaiotto, Ferando Bacal

  • Open Access

    Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction

    by Manuela Cristina Ribeiro Dias Barroso, Heleutério da Conceição Nicolau Madogolele, Danielle Louvet Guazzelli, Luis Fernando Bernal da Costa Seguro, Fabiana Goulart Marcondes-Braga, Sandrigo Mangini, Monica Samuel Ávila, Gabriel Barros Aulicino, Iascara Wozniak Campos, Samuel Padovani Steffen, et al.

    Introduction Cardiac sarcoidosis (CS) is an uncommon yet potentially life-threatening manifestation of systemic sarcoidosis. Recurrence of CS following heart transplantation (HTx) is an exceedingly rare event and presents a significant diagnostic challenge. […] Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction Introduction Cardiac sarcoidosis (CS) is an uncommon yet potentially life-threatening manifestation of systemic sarcoidosis. Recurrence of CS following heart transplantation (HTx) is an exceedingly rare event and presents a significant diagnostic challenge. […] Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction

  • Open Access

    Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto

    by Manuela Cristina Ribeiro Dias Barroso, Heleutério da Conceição Nicolau Madogolele, Danielle Louvet Guazzelli, Luis Fernando Bernal da Costa Seguro, Fabiana Goulart Marcondes-Braga, Sandrigo Mangini, Monica Samuel Ávila, Gabriel Barros Aulicino, Iascara Wozniak Campos, Samuel Padovani Steffen, et al.

    Introdução A sarcoidose cardíaca (SC) é uma manifestação incomum, porém potencialmente fatal, da sarcoidose sistêmica. A recorrência da SC após transplante cardíaco (TC) é um evento extremamente raro e representa um desafio diagnóstico significativo. […] Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto Introdução A sarcoidose cardíaca (SC) é uma manifestação incomum, porém potencialmente fatal, da sarcoidose sistêmica. A recorrência da SC após transplante cardíaco (TC) é um evento extremamente raro e representa um desafio diagnóstico significativo. […] Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto

  • Open Access

    History and Application of Mechanical Assist Devices as a Bridge to Heart Transplant: A Review and Perspectives in Brazil

    by Alvaro Perazzo, Fabio Antônio Gaiotto, Samuel Padovani Steffen, Shirlyne Fabianni Dias Gaspar Gaspar, Vanessa Simioni Faria, Rebeca Cavalcante Silva Ferreira, Aline Carbonera, Danielle Louvet Guazzelli, Jael Andrea Rioja Gamboa, Leonardo Flud Ideal, et al.

    Mechanical circulatory support (MCS) devices have evolved significantly over the past decades and play a vital role in managing end-stage heart failure, especially as a bridge to heart transplantation. From the pioneering heart-lung machines to third-generation ventricular assist devices (VADs), MCS technology has advanced to provide more durable, efficient, and safer options for both shortand long-term support. This review outlines the historical development of mechanical assist devices, the types of available supports - ranging from intra-aortic balloon pumps and extracorporeal membrane oxygenation to implantable devices like HeartMate 3 - and their clinical indications and complications. Special attention is given to right ventricular dysfunction, thromboembolic and hemorrhagic complications, and infections, which remain major challenges in the management of patients with MCS devices.In Brazil, despite the growing evidence supporting MCS in critically ill patients, access remains limited due to financial and systemic constraints. The review explores the current landscape of device availability in the country, national guidelines, cost-effectiveness data, and the impact of recent changes in transplant allocation criteria that prioritize patients receiving mechanical support. Notably, the approval of long-term VADs for destination therapy in the public health system in 2024 marks a significant milestone.This review offers a comprehensive perspective on MCS utilization, highlighting both global advances and Brazil-specific challenges. By identifying gaps in access and proposing future directions, it advocates for expanded use of these life-saving technologies to improve survival and quality of life in advanced heart failure patients.